Compounds > imatinib mesylate

Page last updated: 2024-09-03

imatinib mesylate and Pityriasis Rosea

imatinib mesylate has been researched along with Pityriasis Rosea in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dimopoulou, M; Konstantopoulos, K; Kourelis, C; Meletis, J; Papadogianni, A	1
Barbagallo, T; Bellani, E; Borroni, G; Brazzelli, V; Orlandi, E; Passamonti, F; Prestinari, F; Roveda, E; Vassallo, C	1

Other Studies

2 other study(ies) available for imatinib mesylate and Pityriasis Rosea

Article	Year
Pityriasis rosea associated with imatinib (STI571, Gleevec). Dermatology (Basel, Switzerland), 2002, Volume: 205, Issue:2 Topics: Adult; Antineoplastic Agents; Benzamides; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pityriasis Rosea; Pyrimidines	2002
Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases. Journal of the American Academy of Dermatology, 2005, Volume: 53, Issue:5 Suppl 1 Topics: Adult; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pityriasis Rosea; Pyrimidines	2005